PCI术后改吸电子烟与继续吸烟的预后比较:韩国全国性研究
该研究基于韩国国民健康保险数据库,纳入17 973例PCI术前3年内吸烟且术后3年内接受健康筛查的成人,按吸烟习惯变化分为继续吸可燃烟、成功戒烟和改吸电子烟组。中位随访2.4年,改吸电子烟者10%和戒烟者13.4%的MACE累积发生率低于继续吸可燃烟者的17%。以继续吸可燃烟者为参照,改吸电子烟和成功戒烟的MACE多变量校正风险比分别为0.82和0.87。
要点
- PCI术后改吸电子烟或戒烟均与MACE风险低于继续吸可燃烟相关。
- 完全转为仅用电子烟者较双重使用者MACE风险更低(HR 0.71)。
- 该研究为观察性队列,不能确立因果关系。
核心结论
- 在因冠心病行PCI的吸烟者中,改吸电子烟(尤其是完全转换)或戒烟与继续吸可燃烟相比,MACE风险降低。
研究设计与样本
- 基于韩国国民健康保险数据库的全国性队列,纳入17 973例≥20岁、PCI术前3年内健康筛查判定为吸烟且术后3年内接受健康筛查的成人。
- 按吸烟习惯变化分为继续吸可燃烟、成功戒烟和改吸电子烟组,改吸电子烟组再分为双重使用和仅用电子烟。
- 主要结局为MACE,即全因死亡、自发性心肌梗死和再次血运重建的复合终点。
主要发现
- 继续吸可燃烟者8951例(49.8%),改吸电子烟者1694例(9.4%),成功戒烟者7328例(40.7%)。
- 中位随访2.4年,MACE累积发生率:改吸电子烟者10%,戒烟者13.4%,继续吸可燃烟者17%。
- 以继续吸可燃烟者为参照,MACE的多变量校正HR:改吸电子烟0.82(95%CI 0.69-0.98),成功戒烟0.87(95%CI 0.79-0.96)。
- 与双重使用者相比,完全转为仅用电子烟与显著更低的MACE风险相关(HR 0.71,95%CI 0.51-0.99)。
临床怎么用
- 对PCI术后仍吸烟的患者,应强调戒烟,并可告知改吸电子烟(尤其完全转换)在观察性研究中与较低MACE风险相关。
- 需结合指南推荐和个体情况讨论电子烟作为减害过渡策略的潜在作用与不确定性。
局限性
- 观察性设计,残余混杂可能影响结果。
- 吸烟状态基于健康筛查时的自我报告,可能存在错分。
- 随访时间中位2.4年,长期预后未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease who have undergone percutaneous coronary intervention (PCI) remains unclear. METHODS: Using a nationwide cohort from the Korean National Health Insurance database, 17 973 adults (≥20 years) identified as smokers (based on a health screening examination within 3 years before PCI) who underwent health screening within 3 years after PCI were enrolled to determine changes in smoking habits. Patients were classified as continued combustible cigarette users, successful quitters, or switchers to E-cigarettes. The group switching to E-cigarettes was further divided into dual users (using both combustible and E-cigarettes) and those exclusively using E-cigarettes. Primary outcomes included major adverse cardiac events (MACEs), a composite of all-cause death, spontaneous myocardial infarction, and repeat revascularization. RESULTS: Among the total population, 8951 patients (49.8%) continued using combustible cigarettes, 1694 (9.4%) were switched to E-cigarettes, and 7328 (40.7%) successfully quit smoking after PCI. During a median follow-up of 2.4 years, the cumulative incidence of MACE was lower among E-cigarette switchers (10%) or quitters (13.4%) than among continued combustible cigarette users (17%). When continued combustible cigarette users were used as the reference, the multivariable-adjusted hazard ratios with 95% confidence intervals for MACE were 0.82 (0.69-0.98) for switchers to E-cigarettes and 0.87 (0.79-0.96) for successful quitters. Compared with dual users, entirely switching to E-cigarettes was associated with a significantly lower MACE risk (hazard ratio 0.71; 95% confidence interval 0.51-0.99). CONCLUSIONS: Among smokers who underwent PCI for coronary artery disease, switching to E-cigarette use (particularly complete transition) or quitting smoking was associated with reduced MACE risk than with continued combustible cigarette use. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT06338761.
引用
- Kang D, Choi KH, Kim H, et al. Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study. Eur Heart J. 2025. PMID: 39429032. doi:10.1093/eurheartj/ehae705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。